(1) Adjusted EBITDA is a non-GAAP financial measure. See the discussion and the reconciliations at the end of this release for additional information. “Our second quarter results demonstrate that our ...

Q4 and FY Revenue of $9.2 million and $38.7 millionQ4 and FY Income from Continuing Operations of $22.8 million and $25.0 million (benefiting from a one-time, non-cash tax-related accounting adjustmen ...

Revenue of $60.7 million, +2.1% vs. 2024GAAP net income (loss) from continuing operations of $2.5 million vs. $4.2 million in 2024GAAP net income (loss) from continuing ...

The MarketWatch News Department was not involved in the creation of this content. Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth ...

Presented below is certain financial information based on the Company’s EBITDA and Adjusted EBITDA. References to “EBITDA” mean earnings (losses) from continuing operations before interest, taxes, ...

(1) See “Non-GAAP Financial Measures” below. Click to enlarge We are extremely pleased with our outstanding results in the second quarter. CommScope net sales of $1.39 billion increased 31.7% from the ...

Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of consumer health products, today announced financial results from continuing operations for the third quarter ended ...

Stock-based compensation represents noncash costs arise from the grant of stock-based awards to employees, consultants and directors. We believe that excluding the effect of stock-based compensation ...

(RTTNews) - Primo Brands Corp. (PRMB), Thursday announced financial results for the first quarter, revealing net income of $34.7 million or $0.09 a share from continuing operations, compared to $33.5 ...

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

Forward Air Corp. reported a third-quarter 2025 net loss of $23.8 million as revenue fell 3.7% to $631.8 million amid its ongoing business transformation. The company’s performance was affected by ...

Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX: IDXG) today announced financial results for the fourth quarte ...